General Information
BounceWatch is an independent company data service, not affiliated with Targazyme. To contact Targazyme, visit targazyme.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Targazyme compare?
A PDF of Targazyme and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Targazyme soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
From the desk
Is Targazyme on your competitive set?
Our desk can watch it and brief you on every move: hiring, funding, leadership, product and pricing.
Book a 7-day ReadoutDiscover More
About Targazyme
Business keywords: biopharmaceutical, enzyme-based therapies, cell therapy, immunotherapy, cancer treatment, regenerative medicine, clinical trials, FDA orphan drug designation, partnerships, medical research, biologic products, fucosylation technology, clinical-grade enzymes, IND application, clinical-stage company
Funding Rounds & Investors (1)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Series A | $60.00M | 2 |
Kyowa Kirin, Texas Wide Open for Business
|
15 Jul 2009 |
Targazyme Alternatives & Competitors
View All AlternativesA clinical stage oncology company developing personalised medicine approaches to cancer; cellular &...
SciTech Development is a Specialty Pharmaceutical Company dedicated to advancing breakthrough cancer...
Seeking New Horizons for Cancer Patients
FAQ About Targazyme
Source: BounceWatch company record for Targazyme, https://bouncewatch.com/company/targazyme, updated 30 December 2024. When citing, please name BounceWatch and link this page.